Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10:10–27.
Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer Statistics, 2025. CA Cancer J Clin. 2025:10–45. https://doi.org/10.3322/caac.21871.
Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. cell. 2023;186:1729–54.
Hayashi A., Hong J., Iacobuzio-Donoghue, CA. We reconsidered the pancreatic cancer genome. Nat Rev Gastrointestinal Roll Hepatol. 2021;18:469–81.
Lashen AG, Wahab N, Toss M, Miligy I, Ghanaam S, Makhlouf S, et al Characterizing intratumoral heterogeneity in breast cancer using artificial intelligence. cancer. 2024;16:3849.
Lee JH, Song GY, Lee J, Kang SR, Moon KM, Choi YD et al. Prediction of immunochemotherapy response for diffuse large B-cell lymphoma using artificial intelligence digital pathology. J Pathol Clinical Research Institute. 2024;10:e12370.
Calderaro J, Ghafari-Laleh N, Zeng Q, Maille P, Fabre L, Pujars A, et al. Deep learning-based phenotypic analysis reclassifies the complex type of hepatocellular cholangiocarcinoma. Nut commune. 2023;14:8290.
Pan X, AbdulJabbar K, Coelho-Lima J, Grapa AI, Zhang H, Cheung AHK et al. Artificial intelligence-based model ANORAK improves the histopathological grade of lung adenocarcinoma. nut gun. 2024;5:347–63.
Wei JW, Tafe LJ, Linnik YA, Vaickus LJ, Tomita N, Hassanpour S. Pathologist-level classification of histological patterns on resected lung adenocarcinoma slides using deep neural networks. Sci Rep. 2019;9:3358.
Fu X, Liu T, Xiong Z, Smaill BH, Stiles MK, Zhao J. Histological image segmentation and fibrosis identification using convolutional neural networks. Comput Biol Med. 2018;98:147–58.
Liao H, Xiong T, Peng J, Xu L, Liao M, Zhang Z et al. Classification and prognosis prediction from histopathological images of hepatocellular carcinoma using a fully automatic pipeline based on machine learning. Ann saag oncol. 2020;27:2359–69.
Jiang B, Bao L, He S, Chen X, Jin Z, Ye Y. Application of deep learning in histopathological image processing of breast cancer: diagnosis, treatment, and prognosis. Breast Cancer Research Institute 2024;26:137.
Wang W, Chen G, Zhang W, Zhang X, Huang M, Li C et al. Important prognostic signaling pathways in pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA-seq data. Hmm, Junette. 2024;143:1109–29.
Barthel S, Falcomata C, Rad R, Theis FJ, Saur D. Single-cell profiling to investigate pancreatic cancer heterogeneity, plasticity, and response to treatment. nut gun. 2023;4:454–67.
Masato Murakawa, Shinji Kawahara, Daisho Takahashi, Yuya Kamioka, Naoto Yamamoto, Shinji Kobayashi, et al. Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma undergoing curative resection. World J Surg Oncol. 2023;21:263.
Claudio Quiros A, Coudray N, Yeaton A, Yang X, Liu B, Le H et al. Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides. Nut commune. 2024;15:4596.
Wang Y, Ali MA, Vallon-Christersson J, Humphreys K, Hartman J, Rantalainen M. Transcriptional intratumoral heterogeneity predicted by deep learning in routine breast pathology slides provides independent prognostic information. Euro J Cancer. 2023;191:112953.
Gao R, Yuan X, Ma Y, Wei T, Johnston L, Shao Y et al. Utilizing TME depicted by histological images to improve cancer prognosis through a deep learning system. Cell Rep Med. 2024;5:101536.
Yuya Inoue, Masaki Takamatsu, Yuya Masuki, Toru Suzuki, Takashi Hamada, Susumu Abe, et al Blood group antigen expression in blood and tumors associated with overall and adjuvant chemotherapy regimen-specific survival outcomes in resected pancreatic cancer. Ann saag oncol. 2025. https://doi.org/10.1245/s10434-025-17289-7.
Japanese pancreatic cancer classification 8th edition by Masato Ishida, Tatsuya Fujii, Masato Kishiwada, Kazuto Shibuya, Masato Satoi, Masato Ueno, et al., Japanese Pancreatic Society. J Hepatobiliary and Pancreatic Sciences. 2024;31:755–68.
World Health Organization. WHO tumor classification: Gastrointestinal tumors. 5th edition Lyon, France: International Agency for Research on Cancer. 2019.
Amin MB, Edge SB, Green FL, Bird DR, Brookland RK, Washington MK, et al. AJCC Cancer Staging Manual. 8th edition New York: Springer. 2017.
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumors. 8th edition Oxford: Wiley-Blackwell. 2017.
Tetsuya Suzuki, Yuya Masugi, Yuya Inoue, Tetsuya Hamada, Masaki Tanaka, Masaki Takamatsu, et al. KRAS variant allele frequency is associated with survival in pancreatic cancer patients, but not with mutation positivity. Cancer science. 2022;113:3097–109.
Yuya Masugi, Masaki Takamatsu, Masaki Tanaka, Kazuya Hara, Yuya Inoue, Tatsuya Hamada, et al. Postoperative mortality and recurrence patterns of pancreatic cancer according to KRAS mutations and expression of CDKN2A, p53, and SMAD4. J Pathol Clinical Research Institute. 2023;9:339–53.
Kazuto Hayashi, Yuya Ono, Masato Takamatsu, Ato Ohba, Hiroshi Ito, Tatsuya Sato, et al. Predicting the recurrence pattern of pancreatic cancer after pancreatic surgery using a histology-based supervised machine learning algorithm: a single-center retrospective study. Ann saag oncol. 2022:4624–34. https://doi.org/10.1245/s10434-022-11471-x.
Howard A, Sandler M, Chu G, Chen LC, Chen B, Tan M, et al. MobileNetV3: Searching for mobile architectures. Published in: Proceedings of the IEEE/CVF International Conference on Computer Vision (ICCV). IEEE; 2019. Pages 1314–24.
Tan M, Lu QV. EfficientNet: Rethinking model scaling for convolutional neural networks. Published in: Proceedings of the 36th International Conference on Machine Learning (ICML). Proc Mach Learn Res. 2019;97:6105–14.
Bryman L, FJ, Olschen RA, Stone CJ. Classification and regression trees. Belmont, CA: Wadsworth International Group. 1984.
Browning L, Jesus C, Maracrino S, Guan Y, White K, Puddle A, et al. Artificial intelligence-based quality assessment of whole pathology slide images within clinical workflows: Evaluation of a “path profiler” in a pathology diagnostic setting. diagnosis. 2024;14:990.
Polonia A, Camperos S, Ribeiro A, Imor I, Pinto D, Biskup Hrzyńska M, et al. Artificial intelligence improves the accuracy of histological classification of breast lesions. This is J. Clin Pasol. 2021;155:527–36.
Shafi S, Palwani AV. Artificial intelligence in pathological diagnosis. Diagnose Pasol. 2023;18:109.
Zhang Y, Yang Z, Chen R, Zhu Y, Liu L, Dong J et al. Histopathology image-based deep learning prediction of prognosis and treatment response in small cell lung cancer. NPJ DigitMed. 2024;7:15.
Yang H, Li W, Ren L, Yang Y, Zhang Y, Ge B et al. Advances in diagnostic and prognostic markers for pancreatic cancer. Oncol Inst 2023;31:83–99.
Yang J, Zhou H, Li H, Zhao F, Tong K. A nomogram incorporating prognostic immuno-inflammatory nutritional scores for pancreatic cancer survival prediction: a retrospective study. BMC cancer. 2024;24:193.
Liu B, Fu T, He P, Du C, Xu K. Construction of a 5-gene prognostic model based on immune-related genes for pancreatic cancer survival prediction. Biosci Rep. 2021;41:20204301.
Groot VP, Gemenetsis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA, et al. Definition and prediction of early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Anne Sarg. 2019;269:1154–62.
Wang L, Liu Z, Liang R, Wang W, Zhu R, Li J et al. A comprehensive machine learning survival framework develops a consensus model in a large multicenter cohort of pancreatic cancer. elife. 2022;11:e80150.
Toriola AT, Ziegler M, Li Y, Pollak M, Stolzenberg-Solomon R. Circulating insulin-like growth factor and prediagnosis of pancreatic cancer survival. Ann saag oncol. 2017;24:3212–9.
Huang XY, Huang ZL, Yang JH, Xu YH, Sun JS, Zheng Q, et al. IGFBP-3 from pancreatic cancer cells contributes to muscle wasting. J Exp Clin Cancer Res. 2016;35:46.
Tetsuya Hirakawa, Masato Yashiro, Akira Murata, Kazuya Hirata, Kazuya Kimura, Ryo Amano et al. IGF-1 receptor and IGF-binding protein-3 may predict the prognosis of patients with resectable pancreatic cancer. BMC cancer. 2013;13:392.
Tetsuya Yoneyama, Tetsuya Otsuki, Kazuya Honda, Masaki Kobayashi, Masaki Iwasaki, Yuya Uchida, et al Identification of IGFBP2 and IGFBP3 as compensatory biomarkers of CA19-9 in early-stage pancreatic cancer using a combination of antibody-based and LC-MS/MS-based proteomics. PLoS ONE. 2016;11:e0161009.
Karagiannidis I, Jerman SJ, Jacenik D, Phinney BB, Yao R, Prossnitz ER, et al. G-CSF and G-CSFR modulate CD4 and CD8 T cell responses to promote colon tumor growth and represent potential therapeutic targets. Front Immunol. 2020;11:1885.
Huang M, Zhang L, Wu Y, Zhou X, Wang Y, Zhang J et al. CSF3R as a potential prognostic biomarker and immunotherapy target in glioma. Cent Euro J Immunol. 2024;49:155–68.
